{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:15Z","timestamp":1792267395940,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbr.2019.112397","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T02:34:06Z","timestamp":1574994846000},"page":"112397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress"],"prefix":"10.1016","volume":"379","author":[{"given":"Jiancheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youge","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.112397_bib0005","author":"World Health Organization"},{"key":"10.1016\/j.bbr.2019.112397_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"S\u00f6zen","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.bbr.2019.112397_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-007-0449-2","article-title":"Depression and osteoporosis: epidemiology and potential mediating pathways","volume":"19","author":"Mezuk","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbr.2019.112397_bib0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tem.2009.05.003","article-title":"Depression as a risk factor for osteoporosis","volume":"20","author":"Cizza","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbr.2019.112397_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0030-1252020","article-title":"Depression and osteoporosis: a research synthesis with meta-analysis","volume":"42","author":"Cizza","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbr.2019.112397_bib0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00198-009-0918-x","article-title":"Depression and low bone mineral density: a meta-analysis of epidemiologic studies","volume":"20","author":"Wu","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbr.2019.112397_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biopsych.2009.03.016","article-title":"Major depression is a risk factor for low bone mineral density: a meta-analysis","volume":"66","author":"Yirmiya","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112397_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.489","article-title":"Bone density and depressive disorder: a meta-analysis","volume":"6","author":"Schweiger","year":"2016","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbr.2019.112397_bib0045","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(97)09528-7","article-title":"Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people","volume":"351","author":"Liu","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2019.112397_bib0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-200730020-00006","article-title":"Psychotropic medications and the risk of fracture: a meta-analysis","volume":"30","author":"Takkouche","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.bbr.2019.112397_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.afos.2017.05.002","article-title":"Serotonin reuptake inhibitors and bone health: a review of clinical studies and plausible mechanisms","volume":"3","author":"Wadhwa","year":"2017","journal-title":"Osteoporos. Sarcopenia"},{"key":"10.1016\/j.bbr.2019.112397_bib0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ypmed.2018.05.008","article-title":"Nutrition status, bone mass density, and selective serotonin reuptake inhibitors","volume":"113","author":"Kindilien","year":"2018","journal-title":"Prev. Med."},{"key":"10.1016\/j.bbr.2019.112397_bib0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis","volume":"51","author":"Rizzoli","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bbr.2019.112397_bib0070","first-page":"299","article-title":"Targeting the RANK\/RANKL\/OPG signaling pathway: a novel approach in the management of osteoporosis","volume":"8","author":"Hamdy","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbr.2019.112397_bib0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","article-title":"Osteoporosis in inflammatory bowel disease","volume":"122","author":"Ali","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbr.2019.112397_bib0080","first-page":"209","article-title":"Rank\/Rankl\/opg: literature review","volume":"36","author":"Silva","year":"2011","journal-title":"Acta Reumatol. Port."},{"key":"10.1016\/j.bbr.2019.112397_bib0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2019.00629","article-title":"The RANKL-RANK axis: a bone to thymus round trip","volume":"10","author":"Sobacchi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2019.112397_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","article-title":"Denosumab: anti-RANKL antibody","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bbr.2019.112397_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40266-018-0525-7","article-title":"Denosumab: a review in postmenopausal osteoporosis","volume":"35","author":"Deeks","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbr.2019.112397_bib0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1759720X18805759","article-title":"New and emerging concepts in the use of denosumab for the treatment of osteoporosis","volume":"10","author":"Lewiecki","year":"2018","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.bbr.2019.112397_bib0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/joim.12873","article-title":"Treating osteoporosis to prevent fractures: current concepts and future developments","volume":"285","author":"Lorentzon","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbr.2019.112397_bib0110","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ijnp\/pyx100","article-title":"Role of inflammatory bone markers in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model","volume":"21","author":"Zhang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2019.112397_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111904","article-title":"Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model","volume":"368","author":"Xiong","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112397_bib0120","doi-asserted-by":"crossref","first-page":"37023","DOI":"10.1074\/jbc.M111.246280","article-title":"Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts","volume":"286","author":"Furuya","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.112397_bib0125","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1248\/bpb.b18-00026","article-title":"Anti-mouse RANKL antibodies inhibit alveolar bone destruction in periodontitis model mice","volume":"41","author":"Kuritani","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbr.2019.112397_bib0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nprot.2011.361","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbr.2019.112397_bib0135","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112397_bib0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112397_bib0145","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.112397_bib0150","first-page":"228","article-title":"Rapid and sustained antidepressant action of the mGlu2\/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine","volume":"20","author":"Dong","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2019.112397_bib0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbr.2019.112397_bib0160","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/mp.2017.109","article-title":"Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder","volume":"23","author":"Kadriu","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112397_bib0165","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1038\/tp.2017.112","article-title":"Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis","volume":"7","author":"Zhang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112397_bib0170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/cer-2018-0085","article-title":"Impact of selective serotonin reuptake inhibitors in the veteran population: 10-year risk outcomes","volume":"8","author":"Brinton","year":"2019","journal-title":"J. Comp. Eff. Res."},{"key":"10.1016\/j.bbr.2019.112397_bib0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psychres.2019.04.006","article-title":"Effect of selective serotonin reuptake inhibitors on markers of bone loss","volume":"276","author":"Kumar","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2019.112397_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-018-0036-5","article-title":"Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis","volume":"7","author":"Nakai","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.bbr.2019.112397_bib0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/14737175.2019.1554434","article-title":"An update on ketamine and its two enantiomers as rapid-acting antidepressants","volume":"19","author":"Zhang","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbr.2019.112397_bib0190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbr.2019.112397_bib0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112397_bib0200","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1038\/s41598-017-12811-8","article-title":"Establishment of a repeated social defeat stress model in female mice","volume":"7","author":"Takahashi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2019.112397_bib0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2019.05.005","article-title":"Fighting females: neural and behavioral consequences of social defeat stress in female mice","volume":"86","author":"Newman","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112397_bib0210","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.biopsych.2019.08.007","article-title":"Adapting social defeat stress for female mice using species-typical interfemale aggression","volume":"86","author":"Logan","year":"2019","journal-title":"Biol. Psychiatry"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819314263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819314263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:14:07Z","timestamp":1759065247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432819314263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":42,"alternative-id":["S0166432819314263"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112397","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112397"}}